Abstract

Transcriptome–wide association studies (TWAS) have identified several genes that are associated with qualitative traits. In this work, we performed TWAS using quantitative traits and predicted gene expressions in six brain subcortical structures in 286 mild cognitive impairment (MCI) samples from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort. The six brain subcortical structures were in the limbic region, basal ganglia region, and cerebellum region. We identified 9, 15, and 6 genes that were stably correlated longitudinally with quantitative traits in these three regions, of which 3, 8, and 6 genes have not been reported in previous Alzheimer’s disease (AD) or MCI studies. These genes are potential drug targets for the treatment of early–stage AD. Single–Nucleotide Polymorphism (SNP) analysis results indicated that cis–expression Quantitative Trait Loci (cis–eQTL) SNPs with gene expression predictive abilities may affect the expression of their corresponding genes by specific binding to transcription factors or by modulating promoter and enhancer activities. Further, baseline structure volumes and cis–eQTL SNPs from correlated genes in each region were used to predict the conversion risk of MCI patients. Our results showed that limbic volumes and cis–eQTL SNPs of correlated genes in the limbic region have effective predictive abilities.

Highlights

  • The primary goal of Alzheimer’s Disease Neuroimaging Initiative (ADNI) is to test whether findings from serial magnetic resonance imaging (MRI), positron emission tomography (PET), other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of Mild Cognitive Impairment (MCI) and early Alzheimer’s disease (AD)

  • Seven, and three genes were related to AD or MCI, while three (NOXRED1, MYL6B, and FAM162B), eight (RELCH, IRX3, RELL1, TMEM50A, SETD4, TMEM253, HPS3, SLC26A10), and six (SLC6A16, SLC10A5, ENSG00000272542, LINC00958, FCGRT, TRPM4) genes were potentially correlated to AD or MCI in limbic region, basal ganglia region, and cerebellum region, respectively

  • We found that limbic region structure volumes and cis–eQTL Single–Nucleotide Polymorphism (SNP) derived from longitudinally stable correlated genes in the limbic region showed effective conversion predictive ability

Read more

Summary

Introduction

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Alzheimer’s disease (AD) is a progressive and irreversible neurodegenerative disorder, accounting for more than 75% of all dementia events worldwide [1]. Of individuals over 80 years of age suffer from AD around the world [2]. Mild Cognitive Impairment (MCI) is the preclinical stage of AD and is clinically heterogeneous [3]

Objectives
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call